European (re)insurance stocks fall as coronavirus drug flops in early trial

European and Asia-Pacific (re)insurance stocks have fallen after an overnight report raised doubts over a potential coronavirus treatment and as the economic toll of the outbreak becomes clearer.

 

Want to read this article?

 

For details on how to subscribe or for all commercial opportunities, including advertising, please contact:

Andy Stone

Sales manager

+44 (0) 77 4160 9204

andy.stone@thomsonreuters.com

    Ricky Lamey

    Business development executive

    ricky.lamey@thomsonreuters.com